Substitution for protease inhibitors in HIV therapy.
Mikhail
Erian
E
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D035061:Control Groups; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced*; D010349:Patient Compliance; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*
D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors